Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | RAC2 | P15153 | 1/20 | 0.33 |
| ▸ | RAC3 | P60763 | 1/20 | 0.33 |
| ▸ | CDC42 | P60953 | 1/20 | 0.33 |
| ▸ | RAC1 | P63000 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22606852 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1NPSR1RAC2 | |
| SCHEMBL20201843 | 0.82 | KDM4E (0.48) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL20201846 | 0.82 | KDM4E (0.48) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL18407466 | 0.81 | KDM4E (0.51) | KDM4EATML3MBTL1NPSR1HDAC4 | |
| SCHEMBL15159276 | 0.80 | ATM (0.44) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL29275150 | 0.80 | KDM4E (0.39) | KDM4EATML3MBTL1NPSR1HDAC4 | |
| SCHEMBL30961239 | 0.80 | KDM4E (0.39) | KDM4EATML3MBTL1NPSR1HDAC4 | |
| SCHEMBL801175 | 0.79 | KDM4E (0.52) | KDM4EATML3MBTL1NPSR1HDAC4 | |
| SCHEMBL29512004 | 0.79 | KDM4E (0.52) | KDM4EATML3MBTL1NPSR1HDAC4 | |
| SCHEMBL19931136 | 0.79 | KDM4E (0.49) | KDM4EATML3MBTL1NPSR1HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240008358-A1 | TRIPLET QUENCHING | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-01-04 | — | — | US | disclosed |
| WO-2023157640-A1 | SEMICONDUCTOR NANOPARTICLES AND METHOD FOR PRODUCING SAME | 国立大学法人大阪大学 | 2023-08-24 | — | — | WO | disclosed |
| US-20220112996-A1 | JEWELRY AND GEM STONE LIGHTING SYSTEMS AND APPARATUSES AND METHOD MAKING AND USING SAME | ASHLEY PAUL (US) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240008358-A1 | TRIPLET QUENCHING | CCNT1, CCNA1, CCNA2 | KDM4E 2227/4885ATM 1965/4885L3MBTL1 684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.